Clearbridge Biophotonics Inc. – Trademark Portfolio

Entity Type: 03

Clearbridge Biophotonics Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. The owner is based in carlsbad, CA.

suite E

2075 corte del nogal

carlsbad, CA 92011

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Clearbridge Biophotonics Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (3 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

9
Computers & Electronics (2 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Clearbridge Biophotonics Inc. have?

Clearbridge Biophotonics Inc. has 3 U.S. trademarks filed with the USPTO.

What trademark classes does Clearbridge Biophotonics Inc. file in?

Clearbridge Biophotonics Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What is Clearbridge Biophotonics Inc.'s trademark registration success rate?

Clearbridge Biophotonics Inc. has a 0% trademark registration rate, with 0 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.